
DBV Technologies to Participate in Upcoming March Investor Conferences
Châtillon, France, March 4, 2026 DBV Technologies to Participate in Upcoming March Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a late-stage biopharmaceutical company, today announced the company will participate at the following investor conferences in March: Citizens Life Sciences Conference – March 10, 2026 Format: Fireside Chat Time: 1:40pm ET Leerink Partners Global Healthcare Conference – March 11, 2026 Format: 1 on 1 Meetings Sign up to watch the live webcast of the Citizens JMP presentation here. A replay will also be available on the Events section of the Company's website 90 days after the event.


















